Although the overall incidence of fungal infections in liver transplant recipients has declined, these infections still contribute significantly to the morbidity and mortality of patients with risk factors for infection. Although antifungal prophylaxis has been widely studied and practiced, no conse
β¦ LIBER β¦
Outcomes of antifungal prophylaxis in high-risk liver transplant recipients
β Scribed by S. Hadley; C. Huckabee; P.G. Pappas; J. Daly; J. Rabkin; C.A. Kauffman; R.M. Merion; A.W. Karchmer
- Book ID
- 110904273
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 197 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1398-2273
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Antifungal prophylaxis in liver transpla
β
Gregory A. Eschenauer; Simon W. Lam; Peggy L. Carver
π
Article
π
2009
π
John Wiley and Sons
π
English
β 169 KB
Erratum: Antifungal prophylaxis in liver
β
Gregory A. Eschenauer; Simon W. Lam; Peggy L. Carver
π
Article
π
2010
π
John Wiley and Sons
π
English
β 120 KB
UNOS status 4 (life support in ICU) 146 6.3 (2.4-16.7) George 1997 ( 14 ) Donor CMV ΓΎ/recipient -146 4.8 (2.0-11.8) George 1997 ( 14 ) UNOS class I (life support in ICU) 172 3.5 (1.7-7.0) Winston 1999 ( 23 ) Fungal colonization at baseline 172 2.3 (1.2-4.3) Winston 1999 ( 23 ) Pretransplant SCr 3 mg
Fluconazole prophylaxis for high-risk li
β
Nelson Kung; Neil Fisher; Bridget Gunson; Mark Hastings; David Mutimer
π
Article
π
1995
π
The Lancet
π
English
β 317 KB
Antifungal prophylaxis in liver transpla
β
Gianni Biancofiore,Maria L. Bindi,Rubia Baldassarriβ¦
π
Article
π
2002
π
Springer
π
English
β 89 KB
Antifungal prophylaxis in liver transpla
β
Gianni Biancofiore; Maria L. Bindi; Rubia Baldassarri; Anna Maria Romanelli; Gab
π
Article
π
2002
π
Springer
π
English
β 609 KB
Oral ganciclovir versus valganciclovir f
β
R.L. Brady; K. Green; C. Frei; P. Maxwell
π
Article
π
2009
π
John Wiley and Sons
π
English
β 121 KB